An Activity-Based Assay to Screen for PRMT1 Inhibitors

基于活动的 PRMT1 抑制剂筛选试验

基本信息

  • 批准号:
    8324861
  • 负责人:
  • 金额:
    $ 4.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-05-01 至 2014-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Protein Arginine Methyltransferases (PRMTs) catalyze the addition of a methyl group from S- adenosylmethionine to guanidino nitrogen atoms on arginine residues. Arginine methylation of NIP45 (NFAT- interacting protein, 45kD) by PRMT1 augments its interaction with NFAT and results in elevated cytokine production in T helper cells. Covalent modification of NIP45 by arginine methylation is a novel mechanism of regulating the expression of NFAT-dependent cytokine genes. We have identified a novel PRMT inhibitor (Cpd 4) that disrupts the interaction between PRMT1 and NIP45, resulting in abrogated NFAT-driven transcription. Indeed, Cpd4 treatment reduces expression of T helper cytokines, such as IFN¿ and IL-17A, leading to diminished inflammation in the delayed type hypersensitivity model, suggesting that PRMT inhibitors may be useful for treating immune-mediated disease. Despite its promising inhibitory profile, Cpd 4 is only biologically active at high concentrations (100¿M), making it unfavorable for therapeutic development. In response to PAR-09-129, in conjunction with the nearby Scripps MLPCN center, we propose to identify PRMT 1 inhibitors in a high throughput screen of the 300,000+ NIH small molecule library, measuring changes in the kinetics of active-site labeling with fluorescently labeled maleimide probe in the presence of inhibitors by monitoring the fluorescence polarization signal. We will rule out false-positive and non-selective primary hits by incorporating our fluopol assay into a secondary gel-based screen. Selective inhibitors will then be tested for their ability to inhibit PRMT1 activity using in vitro methylation assays and using antibodies that specifically recognize cellular targets of PRMT1. Identification of specific PRMT inhibitors would provide us with important tools to probe the importance of PRMT activity in T helper cell function. Since aberrant PRMT1 activity has been associated with cardiovascular, malignant, infectious, and autoimmune disease, it may be a viable therapeutic target for several indications.
描述(由申请人提供):蛋白质精氨酸甲基转移酶(PRMTs)催化从S-腺苷蛋氨酸到精氨酸残基上胍基氮原子的甲基添加。PRMT1对NIP45 (NFAT相互作用蛋白,45kD)的精氨酸甲基化增强了其与NFAT的相互作用,并导致T辅助细胞中细胞因子的产生升高。精氨酸甲基化介导NIP45共价修饰是调控nfat依赖性细胞因子基因表达的一种新机制。我们已经确定了一种新的PRMT抑制剂(Cpd 4),它破坏PRMT1和NIP45之间的相互作用,导致nfat驱动的转录被取消。事实上,Cpd4治疗降低了辅助性T细胞因子的表达,如IFN¿和IL-17A,导致延迟型超敏反应模型中的炎症减轻,这表明PRMT抑制剂可能对治疗免疫介导性疾病有用。尽管cpd4具有良好的抑制作用,但它只有在高浓度(100¿M)时才具有生物活性,这对治疗发展不利。为了响应PAR-09-129,我们联合附近的Scripps MLPCN中心,提出在30万+ NIH小分子库的高通量筛选中鉴定PRMT 1抑制剂,通过监测荧光偏振信号,测量抑制剂存在时荧光标记的马来酰亚胺探针活性位点标记动力学的变化。我们将排除假阳性和非选择性原发命中,将我们的氟波检测纳入二次凝胶筛选。然后使用体外甲基化测定和特异性识别PRMT1细胞靶标的抗体来测试选择性抑制剂抑制PRMT1活性的能力。特异性PRMT抑制剂的鉴定将为我们探索PRMT活性在T辅助细胞功能中的重要性提供重要的工具。由于异常的PRMT1活性与心血管、恶性、感染性和自身免疫性疾病有关,因此它可能是几种适应症的可行治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KERRI A MOWEN其他文献

KERRI A MOWEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KERRI A MOWEN', 18)}}的其他基金

Posttranscriptional regulation of TNFa by Carm1 in Macrophages
巨噬细胞中 Carm1 对 TNFa 的转录后调节
  • 批准号:
    8636332
  • 财政年份:
    2013
  • 资助金额:
    $ 4.74万
  • 项目类别:
Posttranscriptional regulation of TNFa by Carm1 in Macrophages
巨噬细胞中 Carm1 对 TNFa 的转录后调节
  • 批准号:
    8786493
  • 财政年份:
    2013
  • 资助金额:
    $ 4.74万
  • 项目类别:
PAD2: An Arginine Deiminase that Regulates Arthritis
PAD2:一种调节关节炎的精氨酸脱亚氨酶
  • 批准号:
    8282488
  • 财政年份:
    2012
  • 资助金额:
    $ 4.74万
  • 项目类别:
An Activity-Based Assay to Screen for PRMT1 Inhibitors
基于活动的 PRMT1 抑制剂筛选试验
  • 批准号:
    8460828
  • 财政年份:
    2012
  • 资助金额:
    $ 4.74万
  • 项目类别:
PAD2: An Arginine Deiminase that Regulates Arthritis
PAD2:一种调节关节炎的精氨酸脱亚氨酶
  • 批准号:
    8523780
  • 财政年份:
    2012
  • 资助金额:
    $ 4.74万
  • 项目类别:
Cytokine Gene Regulation by Modification of Arginine Residues
通过精氨酸残基修饰进行细胞因子基因调控
  • 批准号:
    8075289
  • 财政年份:
    2010
  • 资助金额:
    $ 4.74万
  • 项目类别:
CYTOKINE GENE REGULATION BY MODIFICATION OF ARGININE RESIDUES
通过精氨酸残基的修饰来调节细胞因子基因
  • 批准号:
    8171446
  • 财政年份:
    2010
  • 资助金额:
    $ 4.74万
  • 项目类别:
CYTOKINE GENE REGULATION BY MODIFICATION OF ARGININE RESIDUES
通过精氨酸残基的修饰来调节细胞因子基因
  • 批准号:
    7957844
  • 财政年份:
    2009
  • 资助金额:
    $ 4.74万
  • 项目类别:
The Role of Arginine Methyltransferases in Interferon Signaling
精氨酸甲基转移酶在干扰素信号转导中的作用
  • 批准号:
    7882665
  • 财政年份:
    2008
  • 资助金额:
    $ 4.74万
  • 项目类别:
The Role of Arginine Methyltransferases in Interferon Signaling
精氨酸甲基转移酶在干扰素信号转导中的作用
  • 批准号:
    7507284
  • 财政年份:
    2008
  • 资助金额:
    $ 4.74万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 4.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了